Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10668)
All Articles published online
|
Publishing Process of This Article
|
Sep 28, 2017 (publication date) through Apr 16, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Dubois-Camacho K, Ottum PA, Franco-Muñoz D, De la Fuente M, Torres-Riquelme A, Díaz-Jiménez D, Olivares-Morales M, Astudillo G, Quera R, Hermoso MA. Glucocorticosteroid therapy in inflammatory bowel diseases: From clinical practice to molecular biology. World J Gastroenterol 2017; 23(36): 6628-6638 [PMID: 29085208 DOI: 10.3748/wjg.v23.i36.6628] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i36/6628.htm |
| Number | Citing Articles |
| 1 |
Ming‐Yue Wu, Yun‐Jun Ge, Er‐Jin Wang, Qi‐Wen Liao, Zheng‐Yu Ren, Yang Yu, Guoyuan Zhu, Chun‐Ping Liu, Meng‐Ni Zhang, Huanxing Su, Han‐Ming Shen, Ye Chen, Lei Wang, Yi‐Tao Wang, Min Li, Zhaoxiang Bian, Jin Chai, Richard D Ye, Jia‐Hong Lu. Enhancement of efferocytosis through biased FPR2 signaling attenuates intestinal inflammation. EMBO Molecular Medicine 2023; 15(12) doi: 10.15252/emmm.202317815
|
| 2 |
T. L. Alexandrov, B. A. Nanaeva, T. A. Baranova, I. A. Tishaeva, D. V. Podolskaya, E. S. Peda, O. V. Knyazev, M. V. Shapina. Effect of cytomegalovirus infection on moderate and severe ulcerative colitis. Koloproktologia 2021; 20(3): 28 doi: 10.33878/2073-7556-2021-20-3-28-34
|
| 3 |
Ole Haagen Nielsen, Theresa Louise Boye, John Gubatan, Deepavali Chakravarti, James B. Jaquith, Eric C. LaCasse. Selective JAK1 inhibitors for the treatment of inflammatory bowel disease. Pharmacology & Therapeutics 2023; 245: 108402 doi: 10.1016/j.pharmthera.2023.108402
|
| 4 |
Ravi Bandaru, Smruti Rekha Rout, Omkar S. Kamble, Sangram K. Samal, Bapi Gorain, Amirhossein Sahebkar, Farhan J. Ahmed, Prashant Kesharwani, Rambabu Dandela. Clinical progress of therapeutics and vaccines: Rising hope against COVID-19 treatment. Process Biochemistry 2022; 118: 154 doi: 10.1016/j.procbio.2022.04.011
|
| 5 |
Stephanie Kourakis, Cara A. Timpani, Dean G. Campelj, Patricia Hafner, Nuri Gueven, Dirk Fischer, Emma Rybalka. Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better?. Orphanet Journal of Rare Diseases 2021; 16(1) doi: 10.1186/s13023-021-01758-9
|
| 6 |
Yuxi Zhang, Xinyu Feng, Haiyu Lin, Xue Chen, Puming He, Yuefei Wang, Qiang Chu. Tieguanyin extracts ameliorated DSS-induced mouse colitis by suppressing inflammation and regulating intestinal microbiota. Food & Function 2022; 13(24): 13040 doi: 10.1039/D2FO02781J
|
| 7 |
Osteopathic Primary Care Treatment Options for Ulcerative Colitis. Osteopathic Family Physician 2020; 12(3): 10 doi: 10.33181/12031
|
| 8 |
Melissa J. Grigsby, Tajia L. Green, Debora Lim, Kiho Cho, David G. Greenhalgh. A Novel Human Glucocorticoid Receptor Variant, G459V, is Hyperactive in Response to Steroids. Shock 2021; 56(2): 318 doi: 10.1097/SHK.0000000000001729
|
| 9 |
Amy Han, Olav Olsen, Christopher D’Souza, Jing Shan, Feng Zhao, Jean Yanolatos, Zaruhi Hovhannisyan, Sokol Haxhinasto, Frank Delfino, William Olson. Development of Novel Glucocorticoids for Use in Antibody–Drug Conjugates for the Treatment of Inflammatory Diseases. Journal of Medicinal Chemistry 2021; 64(16): 11958 doi: 10.1021/acs.jmedchem.1c00541
|
| 10 |
Ki-Uk Kim, Jisu Kim, Wan-Hoon Kim, Hyeyoung Min, Chang Hwan Choi. Treatments of inflammatory bowel disease toward personalized medicine. Archives of Pharmacal Research 2021; 44(3): 293 doi: 10.1007/s12272-021-01318-6
|
| 11 |
Molly M. Ford. Crohn's Disease Obstructions. Clinics in Colon and Rectal Surgery 2021; 34(04): 227 doi: 10.1055/s-0041-1729926
|
| 12 |
María Arredondo‐Amador, Carlos J. Aranda, Borja Ocón, Raquel González, Olga Martínez‐Augustin, Fermín Sánchez de Medina. Epithelial deletion of the glucocorticoid receptor (Nr3c1) protects the mouse intestine against experimental inflammation. British Journal of Pharmacology 2021; 178(12): 2482 doi: 10.1111/bph.15434
|
| 13 |
Marco Gentili, Simona Ronchetti, Erika Ricci, Rosanna Di Paola, Enrico Gugliandolo, Salvatore Cuzzocrea, Oxana Bereshchenko, Graziella Migliorati, Carlo Riccardi. Selective CB2 inverse agonist JTE907 drives T cell differentiation towards a Treg cell phenotype and ameliorates inflammation in a mouse model of inflammatory bowel disease. Pharmacological Research 2019; 141: 21 doi: 10.1016/j.phrs.2018.12.005
|
| 14 |
Hui Xu, Yuchen Wang, Peter W. Jurutka, Shen Wu, Yadong Chen, Chongjiang Cao, Guitang Chen, Bei Tian, Suilou Wang, Shujie Cheng. 16α-Hydroxytrametenolic Acid from Poria cocos Improves Intestinal Barrier Function Through the Glucocorticoid Receptor-Mediated PI3K/Akt/NF-κB Pathway. Journal of Agricultural and Food Chemistry 2019; 67(39): 10871 doi: 10.1021/acs.jafc.9b04613
|
| 15 |
Miguel Cainzos-Achirica, Kerri Glassner, Hassan Syed Zawahir, Amit K. Dey, Tanushree Agrawal, Eamonn M.M. Quigley, Bincy P. Abraham, Isaac Acquah, Tamer Yahya, Nehal N. Mehta, Khurram Nasir. Inflammatory Bowel Disease and Atherosclerotic Cardiovascular Disease. Journal of the American College of Cardiology 2020; 76(24): 2895 doi: 10.1016/j.jacc.2020.10.027
|
| 16 |
Leiming Zhang, Yanan Huang, Chuanhong Wu, Yuan Du, Peng Li, Meiling Wang, Xinlin Wang, Yanfang Wang, Yanfei Hao, Tian Wang, Baofeng Fan, Zhuye Gao, Fenghua Fu. Network Pharmacology Based Research on the Combination Mechanism Between Escin and Low Dose Glucocorticoids in Anti-rheumatoid Arthritis. Frontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00280
|
| 17 |
Antonella Vetuschi, Natalia Battista, Simona Pompili, Alfredo Cappariello, Roberta Prete, Agnese Taticchi, Roberto Selvaggini, Giovanni Latella G, Aldo Corsetti, Roberta Sferra. The antiinflammatory and antifibrotic effect of olive phenols and Lactiplantibacillus plantarum IMC513 in dextran sodium sulfate–induced chronic colitis. Nutrition 2022; 94: 111511 doi: 10.1016/j.nut.2021.111511
|
| 18 |
Yaxi Zhou, Diandian Wang, Hao Duan, Shiqi Zhou, Jinhong Guo, Wenjie Yan. The Potential of Natural Oils to Improve Inflammatory Bowel Disease. Nutrients 2023; 15(11): 2606 doi: 10.3390/nu15112606
|
| 19 |
Simona Ronchetti, Marco Gentili, Erika Ricci, Graziella Migliorati, Carlo Riccardi. Glucocorticoid-Induced Leucine Zipper as a Druggable Target in Inflammatory Bowel Diseases. Inflammatory Bowel Diseases 2020; 26(7): 1017 doi: 10.1093/ibd/izz331
|
| 20 |
T. L. Alexandrov, B. A. Nanaeva, T. A. Baranova, I. A. Tishaeva, D. V. Podolskaya, E. S. Peda, O. V. Knyazev, M. V. Shapina. Effect of cytomegalovirus infection on moderate and severe ulcerative colitis. Koloproktologia 2021; 20(3): 28 doi: 10.33878/2073-7556-2021-20-3-28-34
|
| 21 |
Gang Xiang, Minmin Fan, Yuzhu Ma, Miao Wang, Jian Gao, Jingwei Chen, Xin Li, Wenwen Xue, Yixuan Wang, Huiyuan Gao, Yan Shen, Qiang Xu. Anti-inflammatory actions of Caesalpinin M2 in experimental colitis as a selective glucocoricoid receptor modulator. Biochemical Pharmacology 2018; 150: 150 doi: 10.1016/j.bcp.2018.02.003
|
| 22 |
Julia Paik. Ozanimod: A Review in Ulcerative Colitis. Drugs 2022; 82(12): 1303 doi: 10.1007/s40265-022-01762-8
|
| 23 |
Ondřej Kučerka, Martin Malý, Petra Mináriková, Jan M. Horáček. ATHEROSCLEROTIC CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. Military Medical Science Letters 2024; doi: 10.31482/mmsl.2024.001
|
| 24 |
Jana Štofilová, Monika Kvaková, Anna Kamlárová, Emília Hijová, Izabela Bertková, Zuzana Guľašová. Probiotic-Based Intervention in the Treatment of Ulcerative Colitis: Conventional and New Approaches. Biomedicines 2022; 10(9): 2236 doi: 10.3390/biomedicines10092236
|
| 25 |
Doha Alghamdi, Abdulrahman Alghamdi. Updates on Corticosteroids. 2023; doi: 10.5772/intechopen.109593
|
| 26 |
Julio Maria Fonseca Chebli, Rogério Serafim Parra, Cristina Flores, Antonio Carlos Moraes, Rodrigo Bremer Nones, Tarcia Nogueira Ferreira Gomes, Ana Maria Bravo Perdomo, Gustavo Scapini, Cyrla Zaltman. Effectiveness and Safety of Ustekinumab for Moderate to Severely Active Crohn’s Disease: Results from an Early Access Program in Brazil. Journal of Clinical Medicine 2022; 11(21): 6481 doi: 10.3390/jcm11216481
|
| 27 |
Heike E. F. Becker, Karlijn Demers, Luc J. J. Derijks, Daisy M. A. E. Jonkers, John Penders. Current evidence and clinical relevance of drug-microbiota interactions in inflammatory bowel disease. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1107976
|
| 28 |
Shuo Yuan, Ke-Si Wang, Huan Meng, Xiao-Ting Hou, Jia-Chen Xue, Bao-Hong Liu, Wen-Wen Cheng, Jiao Li, Hua-Min Zhang, Ji-Xing Nan, Qing-Gao Zhang. The gut microbes in inflammatory bowel disease: Future novel target option for pharmacotherapy. Biomedicine & Pharmacotherapy 2023; 165: 114893 doi: 10.1016/j.biopha.2023.114893
|
| 29 |
M. Eugenia Delgado, Thomas Brunner. The many faces of tumor necrosis factor signaling in the intestinal epithelium. Genes & Immunity 2019; 20(8): 609 doi: 10.1038/s41435-019-0057-0
|
| 30 |
Simona Ronchetti, Erika Ricci, Graziella Migliorati, Marco Gentili, Carlo Riccardi. How Glucocorticoids Affect the Neutrophil Life. International Journal of Molecular Sciences 2018; 19(12): 4090 doi: 10.3390/ijms19124090
|
| 31 |
Yaxi Zhou, Diandian Wang, Wenjie Yan. Treatment Effects of Natural Products on Inflammatory Bowel Disease In Vivo and Their Mechanisms: Based on Animal Experiments. Nutrients 2023; 15(4): 1031 doi: 10.3390/nu15041031
|
| 32 |
Ayumi Ito, Shun Murasugi, Maria Yonezawa, Teppei Omori, Shinichi Nakamura, Katsutoshi Tokushige. A retrospective study to investigate the efficacy and safety of granulocyte and monocyte adsorptive apheresis in patients with primary sclerosing cholangitis with ulcerative colitis. Journal of Clinical Apheresis 2024; 39(1) doi: 10.1002/jca.22099
|
| 33 |
Jolanta Skarbaliene, Jesper Mosolff Mathiesen, Bjarne Due Larsen, Christian Thorkildsen, Yvette Miata Petersen. Glepaglutide, a novel glucagon-like peptide-2 agonist, has anti-inflammatory and mucosal regenerative effects in an experimental model of inflammatory bowel disease in rats. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02716-4
|
| 34 |
Chunlan Huang, Zehua Huang, Ling Ding, Yang Fu, Junjie Fan, Qixiang Mei, Lihong Lou, Jingjing Wang, Nuoming Yin, Yingying Lu, Sanwei Guo, Yue Zeng. Fecal microbiota transplantation versus glucocorticoids for the induction of remission in mild to moderate ulcerative colitis. Journal of Translational Medicine 2022; 20(1) doi: 10.1186/s12967-022-03569-3
|
| 35 |
Faridha Ilyas. Successful low-dose corticosteroid treatment of aggressive pyoderma gangrenosum with irritable bowel syndrome: a case report. Acta Dermatovenerologica Alpina Pannonica et Adriatica 2022; 31(3) doi: 10.15570/actaapa.2022.17
|
| 36 |
B Joanna Niklinska-Schirtz, Subra Kugathasan. Anti-TNF Therapy Is Emerging as the Primary Treatment Modality in Pediatric Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2019; doi: 10.1093/ibd/izz158
|
| 37 |
Lauren A. George, Raymond K. Cross. Treatment of Ulcerative Colitis with Steroids (in Whom, How Long, What Dose, What Form). Gastroenterology Clinics of North America 2020; 49(4): 705 doi: 10.1016/j.gtc.2020.08.001
|
| 38 |
Martina Franzin, Katja Stefančič, Marianna Lucafò, Giuliana Decorti, Gabriele Stocco. Microbiota and Drug Response in Inflammatory Bowel Disease. Pathogens 2021; 10(2): 211 doi: 10.3390/pathogens10020211
|
| 39 |
Yan Chen, Ping Wang, Yin Zhang, Xiao-Yu Du, Ying-Jian Zhang. Comparison of effects of aminosalicylic acid, glucocorticoids and immunosuppressive agents on the expression of multidrug-resistant genes in ulcerative colitis. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-19612-8
|
| 40 |
Fernando Magro, Gonçalo Cordeiro, Andreia Martins Dias, Maria Manuela Estevinho. Inflammatory Bowel Disease – Non-biological treatment. Pharmacological Research 2020; 160: 105075 doi: 10.1016/j.phrs.2020.105075
|
| 41 |
T. A. Baranova, O. V. Knyazev, I. A. Tishaeva. Modern principles of severe ulcerative colitis attack therapy: from simple to complex. Experimental and Clinical Gastroenterology 2022; (9): 268 doi: 10.31146/1682-8658-ecg-205-9-268-275
|
| 42 |
Meiling Wang, Hongyan Li, Yanfang Wang, Yanfei Hao, Yanan Huang, Xinlin Wang, Yongying Lu, Yuan Du, Fenghua Fu, Wenyu Xin, Leiming Zhang. Anti-Rheumatic Properties of Gentiopicroside Are Associated With Suppression of ROS-NF-κB-NLRP3 Axis in Fibroblast-Like Synoviocytes and NF-κB Pathway in Adjuvant-Induced Arthritis. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00515
|
| 43 |
Dandan Liu, Varma Saikam, Katie A. Skrada, Didier Merlin, Suri S. Iyer. Inflammatory bowel disease biomarkers. Medicinal Research Reviews 2022; 42(5): 1856 doi: 10.1002/med.21893
|
| 44 |
Theresa Hunter, April N. Naegeli, Chi Nguyen, Mingyang Shan, Joseph L. Smith, Hiangkiat Tan, Klaus Gottlieb, Keith Isenberg. Medication use among patients with Crohn’s disease or ulcerative colitis before and after the initiation of advanced therapy. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02584-4
|
| 45 |
Jian Guo, Ruiya Zhang, Yiqing Zhao, Junping Wang. MiRNA-29c-3p Promotes Intestinal Inflammation via Targeting Leukemia Inhibitory Factor in Ulcerative Colitis. Journal of Inflammation Research 2021; : 2031 doi: 10.2147/JIR.S302832
|
| 46 |
Jiryeon Jang, Sehoon Jeong. Inflammatory Bowel Disease: Pathophysiology, Treatment, and Disease Modeling. BioChip Journal 2023; 17(4): 403 doi: 10.1007/s13206-023-00118-y
|
| 47 |
Marianna Lucafò, Matteo Bramuzzo, Davide Selvestrel, Prisca Da Lozzo, Giuliana Decorti, Gabriele Stocco. Gender May Influence the Immunosuppressive Actions of Prednisone in Young Patients With Inflammatory Bowel Disease. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.673068
|
| 48 |
Thanh Thanh L. Nguyen, Duan Liu, Huanyao Gao, Zhenqing Ye, Jeong‐Heon Lee, Lixuan Wei, Jia Yu, Lingxin Zhang, Liewei Wang, Tamas Ordog, Richard M. Weinshilboum. Glucocorticoids mediate transcriptome‐wide alternative polyadenylation: Potential mechanistic and clinical implications. Clinical and Translational Science 2022; 15(11): 2758 doi: 10.1111/cts.13402
|
| 49 |
You Sun Kim. Treatment of inflammatory bowel diseases: focusing on 5-aminosalicylates and immunomodulators. Journal of the Korean Medical Association 2021; 64(9): 596 doi: 10.5124/jkma.2021.64.9.596
|
| 50 |
Cynthia Morvillo, Katherine Vinci, Lauren Hedenschoug, Leah Mancini, Carrie Mize, Kayce Tugg, Steven Stein. Risks and Safety of Advanced Therapies and Biologics in Inflammatory Bowel Disease. Gastroenterology Nursing 2020; 43(4): E159 doi: 10.1097/SGA.0000000000000523
|
| 51 |
Sara Hone Lopez, Mathilde Jalving, Rudolf S.N. Fehrmann, Wouter B. Nagengast, Elisabeth G.E. de Vries, Jacco J. de Haan. The gut wall’s potential as a partner for precision oncology in immune checkpoint treatment. Cancer Treatment Reviews 2022; 107: 102406 doi: 10.1016/j.ctrv.2022.102406
|
| 52 |
M. V. Prosberg, H. Kringel, J. S. Kapel, B. S. Kapel, B. L. Fredensborg, A. M. Petersen, L. H. Hansen, D. S. Nielsen, H. S. Kapel, K. R. Jacobsen, L. F. Mikkelsen, C. M. O. Kapel. Pre-clinical evaluation of the effect of co-medication with antibiotics and oral steroids in Göttingen Minipigs on the biological activity of the probiotic medicinal product TSO (Trichuris suis ova). Parasitology Research 2021; 120(2): 743 doi: 10.1007/s00436-020-07004-8
|
| 53 |
Lacey DeVreese, Cynthia Tsien, Sanjay K. Murthy. Encyclopedia of Gastroenterology. 2020; : 248 doi: 10.1016/B978-0-12-801238-3.65640-4
|
| 54 |
Hicheme Hadji, Kawthar Bouchemal. Advances in the treatment of inflammatory bowel disease: Focus on polysaccharide nanoparticulate drug delivery systems. Advanced Drug Delivery Reviews 2022; 181: 114101 doi: 10.1016/j.addr.2021.114101
|
| 55 |
Marco Vincenzo Lenti, Alessandro Armuzzi, Fabiana Castiglione, Massimo Claudio Fantini, Gionata Fiorino, Ambrogio Orlando, Daniela Pugliese, Fernando Rizzello, Maurizio Vecchi, Antonio Di Sabatino. Are we choosing wisely for inflammatory bowel disease care? The IG-IBD choosing wisely campaign. Digestive and Liver Disease 2020; 52(1): 44 doi: 10.1016/j.dld.2019.09.019
|
| 56 |
Rodrigo Quera, Paulina Núñez, Beatriz Sicilia, Lilian Flores, Fernando Gomollón. Corticoides en la enfermedad inflamatoria intestinal: ¿siguen siendo una opción terapéutica?. Gastroenterología y Hepatología 2023; 46(9): 716 doi: 10.1016/j.gastrohep.2022.10.017
|
| 57 |
Giuseppe Leoncini, Vincenzo Villanacci, Maria Grazia Marin, Valentina Crisafulli, Moris Cadei, Elisabetta Antonelli, Claudio Leoci, Gabrio Bassotti. Colonic hypereosinophilia in ulcerative colitis may help to predict the failure of steroid therapy. Techniques in Coloproctology 2018; 22(12): 941 doi: 10.1007/s10151-018-1896-9
|
| 58 |
Areeb Mian, Shujhat Khan. Systematic review: Outcomes of bariatric surgery in patients with inflammatory bowel disease and de-novo IBD development after bariatric surgery. The Surgeon 2023; 21(2): e71 doi: 10.1016/j.surge.2022.04.008
|
| 59 |
Xiaoran Cai, Xiaolei Wang, Muye He, Yan Wang, Minbo Lan, Yuzheng Zhao, Feng Gao. Colon-targeted delivery of tacrolimus using pH-responsive polymeric nanoparticles for murine colitis therapy. International Journal of Pharmaceutics 2021; 606: 120836 doi: 10.1016/j.ijpharm.2021.120836
|
| 60 |
Lisa M. Sevilla, Alba Jiménez-Panizo, Andrea Alegre-Martí, Eva Estébanez-Perpiñá, Carme Caelles, Paloma Pérez. Glucocorticoid Resistance: Interference between the Glucocorticoid Receptor and the MAPK Signalling Pathways. International Journal of Molecular Sciences 2021; 22(18): 10049 doi: 10.3390/ijms221810049
|
| 61 |
Carlos J. Aranda, María Arredondo‐Amador, Borja Ocón, Jose Luis Lavín, Ana María Aransay, Olga Martínez‐Augustin, Fermín Sánchez de Medina. Intestinal epithelial deletion of the glucocorticoid receptor NR3C1 alters expression of inflammatory mediators and barrier function. The FASEB Journal 2019; 33(12): 14067 doi: 10.1096/fj.201900404RR
|
| 62 |
Deborah L. Dillon, Jessica E. Crimaldi. Pathway-Driven Management of Inflammatory Bowel Disease. The Journal for Nurse Practitioners 2020; 16(7): 493 doi: 10.1016/j.nurpra.2020.04.020
|
| 63 |
Tero Ylisaukko-oja, Saku Torvinen, Jaakko Aaltonen, Heikki Nuutinen, Timo Blomster, Airi Jussila, Markku Pajala, Kimmo Salminen, Veikko Moilanen, Kalle Hakala, Mikko Kellokumpu, Kari Toljamo, Henna Rautiainen, Juha Kuisma, Markku Peräaho, Pauliina Molander, Jouni Silvennoinen, Ville Liukkonen, Hans Henricson, Jyrki Tillonen, Mirva Esterinen, Christian Nielsen, Eija Hirsi, Margus Lääne, Ulla-Maija Suhonen, Ilkka Vihriälä, Petri Mäkelä, Mika Puhto, Jari Punkkinen, Hannu Sulonen, Sauli Herrala, Jari Jokelainen, Klaus Tamminen, Taina Sipponen. Characterization of inflammatory bowel disease management by vedolizumab and concomitant treatments in real-life clinical practice. Biologicals 2019; 58: 50 doi: 10.1016/j.biologicals.2019.01.007
|
| 64 |
Karen Dubois-Camacho, David Diaz-Jimenez, Marjorie De la Fuente, Rodrigo Quera, Daniela Simian, Maripaz Martínez, Glauben Landskron, Mauricio Olivares-Morales, John A. Cidlowski, Xiaojiang Xu, Guangping Gao, Jun Xie, Jonás Chnaiderman, Ricardo Soto-Rifo, María-Julieta González, Andrea Calixto, Marcela A. Hermoso. Inhibition of miR-378a-3p by Inflammation Enhances IL-33 Levels: A Novel Mechanism of Alarmin Modulation in Ulcerative Colitis. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.02449
|
| 65 |
Tajia L. Green, Stacey M. Leventhal, Debora Lim, Kiho Cho, David G. Greenhalgh. Lipopolysaccharide Stress Induces Cryptic Exon Splice Variants of the Human Glucocorticoid Receptor. Shock 2019; 52(6): 590 doi: 10.1097/SHK.0000000000001318
|
| 66 |
O. P. Alekseeva, S. V. Krishtopenko, A. A. Alekseeva. Using Dose-Effect Relationship for Optimising Systemic Corticosteroid Dosage in Treatment of Inflammatory Bowel Diseases. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2020; 30(5): 18 doi: 10.22416/1382-4376-2020-30-5-18-25
|
| 67 |
Musetta Paglialunga, Sara Flamini, Raffaele Contini, Marta Febo, Erika Ricci, Simona Ronchetti, Oxana Bereshchenko, Graziella Migliorati, Carlo Riccardi, Stefano Bruscoli. Anti-Inflammatory Effects of Synthetic Peptides Based on Glucocorticoid-Induced Leucine Zipper (GILZ) Protein for the Treatment of Inflammatory Bowel Diseases (IBDs). Cells 2023; 12(18): 2294 doi: 10.3390/cells12182294
|
| 68 |
Omid Gholizadeh, Mohammad Mahdi Jafari, Rezvane Zoobinparan, Saman Yasamineh, Raheleh Tabatabaie, Sama Akbarzadeh, Parya Amini, Majid Eslami, Bahman Yousefi, Mehdi Dadashpour. Recent advances in treatment Crimean–Congo hemorrhagic fever virus: A concise overview. Microbial Pathogenesis 2022; 169: 105657 doi: 10.1016/j.micpath.2022.105657
|
| 69 |
Christine A. Tataru, Maude M. David, Jacopo Grilli. Decoding the language of microbiomes using word-embedding techniques, and applications in inflammatory bowel disease. PLOS Computational Biology 2020; 16(5): e1007859 doi: 10.1371/journal.pcbi.1007859
|
| 70 |
Mireia Tena-Garitaonaindia, María Arredondo-Amador, Cristina Mascaraque, Maitane Asensio, Jose J.G. Marin, Olga Martínez-Augustin, Fermín Sánchez de Medina. Modulation of intestinal barrier function by glucocorticoids: Lessons from preclinical models. Pharmacological Research 2022; 177: 106056 doi: 10.1016/j.phrs.2022.106056
|
| 71 |
Vikash Jaiswal, Nitya Batra, Mehak Dagar, Swatika Butey, Helen Huang, Jia Ee Chia, Sidra Naz, Evbayekha O. Endurance, Nishchita Raj, Srushti Patel, Dipansha Maroo, Song Peng Ang, Muhammed Hanif, Dattatreya Mukherjee, Zouina Sarfraz, Abhigan Babu Shrestha, David Song. Inflammatory bowel disease and associated cardiovascular disease outcomes: A systematic review. Medicine 2023; 102(6): e32775 doi: 10.1097/MD.0000000000032775
|
| 72 |
Marcello Imbrizi, Fernando Magro, Claudio Saddy Rodrigues Coy. Pharmacological Therapy in Inflammatory Bowel Diseases: A Narrative Review of the Past 90 Years. Pharmaceuticals 2023; 16(9): 1272 doi: 10.3390/ph16091272
|
| 73 |
Dolores Sgambato, Francesca Gimigliano, Cristiana De Musis, Antimo Moretti, Giuseppe Toro, Emanuele Ferrante, Agnese Miranda, Domenico De Mauro, Lorenzo Romano, Giovanni Iolascon, Marco Romano. Bone alterations in inflammatory bowel diseases. World Journal of Clinical Cases 2019; 7(15): 1908-1925 doi: 10.12998/wjcc.v7.i15.1908
|
| 74 |
Yu Hu, Zhen Ye, Mingquan Wu, Yingqi She, Linzhen Li, Yujie Xu, Kaihua Qin, Zhipeng Hu, Maoyi Yang, Fating Lu, Qiaobo Ye. The Communication Between Intestinal Microbiota and Ulcerative Colitis: An Exploration of Pathogenesis, Animal Models, and Potential Therapeutic Strategies. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.766126
|
| 75 |
Xiong Sun, Yao Huang, Ya-Li Zhang, Dan Qiao, Yan-Cheng Dai. Research advances of vasoactive intestinal peptide in the pathogenesis of ulcerative colitis by regulating interleukin-10 expression in regulatory B cells. World Journal of Gastroenterology 2020; 26(48): 7593-7602 doi: 10.3748/wjg.v26.i48.7593
|
| 76 |
Pan Xu, Montserrat Elizalde, Ad Masclee, Marieke Pierik, Daisy Jonkers. Corticosteroid enhances epithelial barrier function in intestinal organoids derived from patients with Crohn’s disease. Journal of Molecular Medicine 2021; 99(6): 805 doi: 10.1007/s00109-021-02045-7
|
| 77 |
Waqar Arif Rasool Chaudhry, Muhammad Ashfaq, Parvinder Kaur, Mahendra Kumar, Maria Faraz, Jahanzeb Malik, Amin Mehmoodi. Cardiovascular risk assessment in inflammatory bowel disease with coronary calcium score. Annals of Medicine & Surgery 2024; 86(3): 1496 doi: 10.1097/MS9.0000000000001652
|
| 78 |
Ewa Dudzińska, Aneta Strachecka, Paulina Gil-Kulik, Janusz Kocki, Jacek Bogucki, Natalya Shemedyuk, Magdalena Gryzinska. Influence of the Treatment Used in Inflammatory Bowel Disease on the Protease Activities. International Journal of General Medicine 2020; : 1633 doi: 10.2147/IJGM.S267036
|
| 79 |
A. Treveil, P. Sudhakar, Z. J. Matthews, T. Wrzesiński, E. J. Jones, J. Brooks, M. Ölbei, I. Hautefort, L. J. Hall, S. R. Carding, U. Mayer, P. P. Powell, T. Wileman, F. Di Palma, W. Haerty, T. Korcsmáros. Regulatory network analysis of Paneth cell and goblet cell enriched gut organoids using transcriptomics approaches. Molecular Omics 2020; 16(1): 39 doi: 10.1039/C9MO00130A
|
| 80 |
Mariusz G. Fleszar, Paulina Fortuna, Marek Zawadzki, Paweł Hodurek, Iwona Bednarz-Misa, Wojciech Witkiewicz, Małgorzata Krzystek-Korpacka. Sex, Type of Surgery, and Surgical Site Infections Are Associated with Perioperative Cortisol in Colorectal Cancer Patients. Journal of Clinical Medicine 2021; 10(4): 589 doi: 10.3390/jcm10040589
|
| 81 |
Teresa Y. Oh, Tatyana Hofmekler, A. Jay Freeman. Update in Pediatrics. 2023; : 369 doi: 10.1007/978-3-031-41542-5_15
|
| 82 |
Tomofumi Miura, Ayumi Okizaki, Hideaki Hasuo, Eriko Satomi, Keita Tagami, Kengo Imai, Takashi Kojima, Hironaga Satake, Hiroto Ishiki, Akira Inoue, Takuhiro Yamaguchi. Dexamethasone 8 mg for Cancer-Related Fatigue in Inpatients with Advanced Cancer Undergoing Palliative Care: A Multicenter Phase II Trial. Palliative Medicine Reports 2021; 2(1): 316 doi: 10.1089/pmr.2021.0053
|
| 83 |
Lingjie Kong, Siyan Chen, Shenghao Huang, Anzhe Zheng, Sheng Gao, Jianzhong Ye, Chunyan Hua. Challenges and opportunities in inflammatory bowel disease: from current therapeutic strategies to organoid-based models. Inflammation Research 2024; 73(4): 541 doi: 10.1007/s00011-024-01854-z
|
| 84 |
B. Lavoie, J.A. Roberts, M.M. Haag, S.N. Spohn, K.G. Margolis, K.A. Sharkey, J.B. Lian, G.M. Mawe. Gut-derived serotonin contributes to bone deficits in colitis. Pharmacological Research 2019; 140: 75 doi: 10.1016/j.phrs.2018.07.018
|
| 85 |
Stefano Bruscoli, Marta Febo, Carlo Riccardi, Graziella Migliorati. Glucocorticoid Therapy in Inflammatory Bowel Disease: Mechanisms and Clinical Practice. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.691480
|
| 86 |
Rodrigo Quera, Paulina Núñez, Beatriz Sicilia, Lilian Flores, Fernando Gomollón. Corticosteroids in inflammatory bowel disease: Are they still a therapeutic option?. Gastroenterología y Hepatología (English Edition) 2023; 46(9): 716 doi: 10.1016/j.gastre.2022.10.019
|
| 87 |
Christian L. Hvas, Mia Bendix, Anders Dige, Jens F. Dahlerup, Jørgen Agnholt. Current, experimental, and future treatments in inflammatory bowel disease: a clinical review. Immunopharmacology and Immunotoxicology 2018; 40(6): 446 doi: 10.1080/08923973.2018.1469144
|
| 88 |
Ha-Yeon Song, Woo Sik Kim, Jin-Man Kim, Dong-Ho Bak, Jeong Moo Han, Seung-Taik Lim, Eui-Baek Byun. A hydroxyethyl derivative of chrysin exhibits anti-inflammatory activity in dendritic cells and protective effects against dextran sodium salt-induced colitis in mice. International Immunopharmacology 2019; 77: 105958 doi: 10.1016/j.intimp.2019.105958
|
| 89 |
Sybille D. Reichardt, Agathe Amouret, Chiara Muzzi, Sabine Vettorazzi, Jan P. Tuckermann, Fred Lühder, Holger M. Reichardt. The Role of Glucocorticoids in Inflammatory Diseases. Cells 2021; 10(11): 2921 doi: 10.3390/cells10112921
|
| 90 |
Kelly Van Looveren, Charlotte Wallaeys, Claude Libert. Potential of glucocorticoids to treat intestinal inflammation during sepsis. Current Opinion in Pharmacology 2020; 53: 1 doi: 10.1016/j.coph.2019.12.005
|